Alternative Name: | Neuroendocrine, CgA |
|
Clone: | CHGA/1773R |
|
Host: | Rabbit |
|
Isotype: | IgGκ |
|
Immunogen: | Recombinant full length human chromogranin A. |
|
UniProt ID: | P10645 |
|
Species reactivity: | Human
|
|
Applications: | Flow Cytometry, IF, IHC (PS)
|
|
Recommended Dilutions/Conditions: | Flow Cytometry (0.5-1 µg/106 cells in 0.1 mL) Immunofluorescence (1-2 µg/mL) Immunohistochemistry (formalin-fixed paraffin sections) (0.25-0.5 µg/mL for 30 min at RT) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
|
Purity Detail: | Protein A affinity purified. |
|
Formulation: | Liquid. In 1X PBS containing 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide. |
|
Shipping: | Blue Ice |
|
Long Term Storage: | +4°C |
|
Scientific Background: | Chromogranin A is present in neuroendocrine cells throughout the body, including the neuroendocrine cells of the large and small intestine, adrenal medulla and pancreatic islets. It is an excellent marker for carcinoid tumors, pheochromocytomas, paragangliomas, and other neuroendocrine tumors. Co-expression of chromogranin A and neuron specific enolase (NSE) is common in neuroendocrine neoplasms. Reportedly, co-expression of certain keratins and chromogranin indicates neuroendocrine lineage. The presence of strong anti-chromogranin staining and absence of anti-keratin staining should raise the possibility of paraganglioma. The co-expression of chromogranin and NSE is typical of neuroendocrine neoplasms. Most pituitary adenomas and prolactinomas readily express chromogranin. |
|
Regulatory Status: | RUO - Research Use Only |
|